Faslodex Registry: Fulvestrant in Current Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Circulating Tumor Cells in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
- Status
- COMPLETED
- Phase
- PHASE2
Expressive Writing and Adjustment to Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2